Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-01-15

Clinical Trial Update: Polymorphisms in the Human Matrix Metalloproteinase Genes MMP1, MMP3, and MMP9: Genetic Risk Factors of Primary Open Angle Glaucoma? [NA]

View source ↗

Summary

A completed clinical trial investigates whether polymorphisms in MMP1, MMP3, and MMP9 are genetic risk factors for primary open-angle glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Medical University of Vienna | Conditions: Glaucoma | NA | Status: COMPLETED